Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis
- 1 October 1999
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 146 (2) , 249-257
- https://doi.org/10.1016/s0021-9150(99)00145-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Angiotensin, LDL peroxidation and atherosclerosisLife Sciences, 1998
- Angiotensin II Injection into Mice Increases the Uptake of Oxidized LDL by Their Macrophages via a Proteoglycan-Mediated PathwayBiochemical and Biophysical Research Communications, 1997
- Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 1997
- Angiotensin II–Modified LDL Is Taken Up by Macrophages Via the Scavenger Receptor, Leading to Cellular Cholesterol AccumulationArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteinsAtherosclerosis, 1995
- Modified forms of low density lipoprotein and atherosclerosisAtherosclerosis, 1993
- Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.Circulation Research, 1991
- Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.Hypertension, 1990
- Regulation of the mevalonate pathwayNature, 1990
- Human Platelet Angiotensin II Receptors: Regulation by the Circulating Angiotensin Level*Journal of Clinical Endocrinology & Metabolism, 1984